Case Report, J Immunol Tech Infect Dis Vol: 3 Issue: 1
The CD4 Cell Count Interest in HIV-Positive Patients under Antiretroviral Therapy (ART) in a Limited-Resource Country
Kassi K1,2*, Ecra EJ1,2, Djeha D1,2, Yao KJ2, Kacou DE2, Adiko LC2, Kouame K1,2, Kouassi A1,2, Acho AA2, Sangaré A1,2, Gbery IP1,2, Yoboué YP1,2and Kanga JM1,2 |
1Department of Dermatology and Infectiology, Felix Houphouët Boigny University, Abidjan, Côte d’Ivoire |
2Dermatology Department, Teaching Hospital of Treichville, Abidjan, Côte d’Ivoire |
Corresponding author : Dr. Kassi Komenan Department of Dermatology and Infectiology, Felix Houphouët Boigny University, Abidjan, Côte d’Ivoire Tel: 0022507047601 E-mail: siskakomlo@yahoo.fr |
Received: October 22, 2013 Accepted: January 13, 2014 Published: January 17, 2014 |
Citation: Kassi K, Ecra EJ, Djeha D, Yao KJ, Kacou DE, et al,. (2014) The CD4 Cell Count Interest in HIV-Positive Patients under Antiretroviral Therapy (ART) in a Limited-Resource Country. J Immunol Tech Infect Dis 3:1. doi: 10.4172/2329-9541.1000122 |
Abstract
The CD4 Cell Count Interest in HIV-Positive Patients under Antiretroviral Therapy (ART) in a Limited-Resource Country
In 2009, in sub-Saharan Africa, an estimated 22.5 million adults and children were HIV/AIDS infected and an estimated 1.3 million died from HIV-related diseases. By 2010, almost 40% of those in need of ART were enjoying care; significant progress was made compared to 2% in 2003. HIV/AIDS remains under –diagnosed, many patients report late for care or not at all and some do not keep up with the care over time. Therefore World Health Organization (WHO) increased the threshold from less than 200 cell/mm3 to 350 cell/mm3.